Cargando…

Prospective evaluation of whole-body MRI and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients

OBJECTIVES: To evaluate and compare the diagnostic potential of whole-body MRI and whole-body (18)F-FDG PET/MRI for N and M staging in newly diagnosed, histopathologically proven breast cancer. MATERIAL AND METHODS: A total of 104 patients (age 53.4 ± 12.5) with newly diagnosed, histopathologically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruckmann, Nils Martin, Sawicki, Lino M., Kirchner, Julian, Martin, Ole, Umutlu, Lale, Herrmann, Ken, Fendler, Wolfgang, Bittner, Ann-Kathrin, Hoffmann, Oliver, Mohrmann, Svjetlana, Dietzel, Frederic, Ingenwerth, Marc, Schaarschmidt, Benedikt M., Li, Yan, Kowall, Bernd, Stang, Andreas, Antoch, Gerald, Buchbender, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567721/ https://www.ncbi.nlm.nih.gov/pubmed/32333068 http://dx.doi.org/10.1007/s00259-020-04801-2

Ejemplares similares

Prospective comparison of CT and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Comparison of nodal staging between CT, MRI, and [(18)F]-FDG PET/MRI in patients with newly diagnosed breast cancer
por: Morawitz, Janna, et al.
Publicado: (2021)

Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
por: Morawitz, Janna, et al.
Publicado: (2023)

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in (18)F-FDG PET/MRI
por: Bruckmann, Nils Martin, et al.
Publicado: (2022)

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
por: Jannusch, Kai, et al.
Publicado: (2023)

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant?
por: Jannusch, Kai, et al.
Publicado: (2022)

Multiparametric Integrated (18)F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
por: Umutlu, Lale, et al.
Publicado: (2021)

[(18)F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
por: Jannusch, Kai, et al.
Publicado: (2023)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Umutlu, Lale, et al.
Publicado: (2022)

Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography
por: Dietzel, Frederic, et al.
Publicado: (2023)

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
por: Jannusch, Kai, et al.
Publicado: (2023)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

(18)F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
por: Deuschl, Cornelius, et al.
Publicado: (2020)

Reply to Letter to the Editor: “The added benefit of contrast-enhanced CT in the evaluation of incidental FDG-avid colon lesions”
por: Kirchner, Julian, et al.
Publicado: (2020)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI
por: Schaarschmidt, Benedikt Michael, et al.
Publicado: (2015)

Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI
por: Grueneisen, Johannes, et al.
Publicado: (2016)

Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results
por: Chodyla, Michal, et al.
Publicado: (2022)

Accuracy of [(18)F]FDG PET/MRI for the Detection of Liver Metastases
por: Beiderwellen, Karsten, et al.
Publicado: (2015)

Impact of Different Metal Artifact Reduction Techniques on Attenuation Correction of Normal Organs in (18)F-FDG-PET/CT
por: Morawitz, Janna, et al.
Publicado: (2022)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
por: Demircioglu, Aydin, et al.
Publicado: (2020)

Diagnostic Performance of Simultaneous [(18)F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study
por: Langhorst, Jost, et al.
Publicado: (2020)

Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)

Optimization of Acquisition time of (68)Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer
por: Lütje, Susanne, et al.
Publicado: (2016)

(18)F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
por: Li, Yan, et al.
Publicado: (2020)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [(18)F]FDG PET/CT compared to the histopathology reference standard
por: Hautzel, Hubertus, et al.
Publicado: (2021)

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
por: Herrmann, Ken, et al.
Publicado: (2015)

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas
por: Chodyla, Michal, et al.
Publicado: (2021)

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Evaluation of (18)F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
por: Weber, Manuel, et al.
Publicado: (2021)

Cardiac PET/MRI—an update
por: Rischpler, C., et al.
Publicado: (2019)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
por: Fragoso Costa, Pedro, et al.
Publicado: (2022)

7 T renal MRI: challenges and promises
por: de Boer, Anneloes, et al.
Publicado: (2016)

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
por: Veit-Haibach, Patrick, et al.
Publicado: (2023)

Diagnostic accuracy of (18)F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
por: Ruhlmann, Verena, et al.
Publicado: (2017)

Diffuse Axonal Injury at Ultra-High Field MRI
por: Moenninghoff, Christoph, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fj1int7ch9thcvbqjk5lrkhapi